UPDATE 1-Boston Scientific cuts profit forecast again as legal costs mount

July 23 (Reuters) - Boston Scientific Corp cut its full-year profit forecast for the second time in the face of rising litigation costs linked to problems with its implantable device used to treat feminine stress urinary incontinence.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.